Factors associated with graft rejection after HLA‐identical marrow transplantation for aplastic anaemia

Summary. One hundred and seventy‐five consecutive patients with severe aplastic anaemia were given high‐dose cyclophosphamide followed by marrow grafts from healthy, HLA‐identical family members, and 168 lived long enough to show engraftment. In 38 patients the graft was rejected and 29 of these died. This analysis, using a binary logistic regression model, was aimed at identifying factors that predicted marrow graft rejection. Five factors correlated with graft rejection: (1) previous blood transfusion; (2) a positive relative response in mixed leucocyte culture indicating sensitization of patient against donor; (3) a low number of marrow cells used for transplantation; (4) marrow grafts from male donors; and (5) lack of infusion of viable donor buffy coat cells in addition to the marrow for transfused patients. The findings confirm the importance of transplanting early before transfusion and indicate that the greatest possible amount of donor marrow (supplemented by stem cells/lymphoid cells derived from the peripheral blood) should be obtained.

[1]  H. Deeg,et al.  Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. , 1983, Annals of internal medicine.

[2]  K. Sullivan,et al.  Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. , 1983, The New England journal of medicine.

[3]  R. Storb,et al.  Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia. , 1983, Experimental hematology.

[4]  E. Gordon-Smith,et al.  USE OF CYCLOSPORIN A IN ALLOGENEIC BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA , 1982, Transplantation.

[5]  K. Sullivan,et al.  Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients , 1982 .

[6]  E. Gluckman,et al.  Bone Marrow Transplantation in Severe Aplastic Anaemia: a Survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) * , 1981, British journal of haematology.

[7]  E. Mellits,et al.  Analysis of factors related to bone marrow graft rejection in aplastic anemia: usefulness of measures of broad alloimmunity as predictors. , 1981, Transplantation proceedings.

[8]  R. Storb,et al.  Studies of the response in mixed leukocyte culture of cells from patients with aplastic anemia to cells from HLA-identical siblings. , 1981, Transplantation.

[9]  A. Rimm,et al.  Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. , 1981, JAMA.

[10]  A. Gratwohl,et al.  Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. , 1981, British medical journal.

[11]  S. Feig,et al.  Prevention of graft rejection following bone marrow transplantation , 1981 .

[12]  R. Storb,et al.  PREDICTION OF MARROW GRAFT REJECTION BY THE LYMPHOCYTE‐MEDIATED CYTOTOXICITY AND ANTIBODY‐DEPENDENT CELL‐MEDIATED CYTOTOXICITY ASSAYS , 1980, Transplantation.

[13]  H. Deeg,et al.  Marrow Transplantation in Thirty "Untransfused" Patients with Severe Aplastic Anemia , 1980, Annals of Internal Medicine.

[14]  D. Purtilo,et al.  Immunological bases for superior survival of females. , 1979, American journal of diseases of children.

[15]  H. Deeg,et al.  Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: antigens involved are expressed on leukocytes and skin epithelial cells but not on platelets and red blood cells. , 1979, Blood.

[16]  A. Allison,et al.  Use of cyclosporin A in allogeneic bone marrow transplantation in the rat , 1979, Nature.

[17]  H. Deeg,et al.  Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. , 1979, Blood.

[18]  J. Adamson,et al.  Growth in vitro of donor marrow cultured with recipient lymphocytes predicts the fate of marrow grafts in transfused DLA-identical dogs. , 1979, Blood.

[19]  R. Storb,et al.  Marrow transplantation for treatment of aplastic anaemia. , 1978, Clinics in haematology.

[20]  J. Dausset,et al.  Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases. , 1978, Transplantation proceedings.

[21]  J. Goodman,et al.  An amplifier cell in hemopoiesis. , 1978, Experimental hematology.

[22]  D. Housman,et al.  Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro , 1978, The Journal of experimental medicine.

[23]  R. Storb,et al.  Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. , 1977, Blood.

[24]  R. Storb,et al.  Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. , 1977, The Journal of clinical investigation.

[25]  R. Storb,et al.  Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. , 1977, The New England journal of medicine.

[26]  H. Koenig,et al.  DIRECT AND ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AGAINST HLA IDENTICAL SIBLING LYMPHOCYTES: Correlation with Marrow Graft Rejection , 1976 .

[27]  R. Storb,et al.  Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections. , 1976, Transplantation.

[28]  Clift,et al.  Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. , 1976, Blood.

[29]  E. Thomas,et al.  CORRELATION OF THE RELATIVE RESPONSE INDEX WITH MARROW GRAFT REJECTION IN PATIENTS WITH APLASTIC ANEMIA , 1976, Transplantation.

[30]  P. Neiman,et al.  Allogeneic marrow grafting for treatment of aplastic anemia. , 1974, Blood.

[31]  P. Neiman,et al.  Aplastic anaemia treated by marrow transplantation. , 1972, Lancet.

[32]  R. Storb,et al.  The effect of prior transfusion on marrow grafts between histocompatible canine siblings. , 1970, Journal of immunology.

[33]  R. Storb,et al.  METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTS , 1970, Transplantation.

[34]  R. Storb,et al.  MARROW GRAFTS BY COMBINED MARROW AND LEUKOCYTE INFUSIONS IN UNRELATED DOGS SELECTED BY HISTOCOMPATIBILITY TYPING , 1968, Transplantation.

[35]  R. Storb,et al.  Marrow Engraftment by Allogeneic Leukocytes in Lethally Irradiated Dogs , 1967 .

[36]  T. Malinin,et al.  PERIPHERAL LEUKOCYTE INFUSION INTO LETHALLY IRRADIATED GUINEA PIGS. , 1965, Blood.

[37]  E. Thomas,et al.  Recovery of lethally irradiated dogs following infusion of autologous marrow stored at low temperature in dimethylsulphoxide. , 1962, Blood.

[38]  G. Hodgson,et al.  Evidence for stem cells in the peripheral blood of mice. , 1962, Blood.

[39]  J. Loutit,et al.  Active and passive immunity to transplantation of foreign bone marrow in lethally irradiated mice. , 1961, British journal of experimental pathology.

[40]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .